Mahadevan, an associate professor of medicine. Nevertheless, our findings do not suggest that a pregnant woman should discontinue the medication. Stopping it actually can be more threatening to both baby and mother because of the chance of miscarriage, preterm birth and low birth fat if the Crohn’s disease flares. The analysis followed five women that are pregnant with Crohn’s disease who had been taking ADA. On the entire day of delivery, ADA levels were measured in the mom, newborn and cord blood. In all cases, the cord blood showed higher levels than the maternal levels – indicating transfer from the mother – and significant ADA amounts were found in three of the newborn samples.At the conference Also, Alere’s Gordon Norman, MD, MBA, Chief Development Officer, will become presenting Beyond Theory: Implementing a Patient-Centric Health Ecosystem on Thursday, 10 from 10:30-11:30 a June.m. AHIP 2010 marks a significant milestone for Alere, provides Underwood. It’s the first time that our clients and prospects will see the ‘new’ Alere, and it offers us a system to talk about important information also to showcase Alere’s comprehensive solutions. We’re eager to demonstrate how Alere empowers people to take charge of their personal health in the home and how exactly we provide physicians with usage of timely and actionable info that drives better healthcare decisions and allows them to even more appropriately and effectively direct care.